The institute is partnering with universities, non-university institutions, health insurance funds and pharmaceutical companies in the conduct of scientific projects in the fields of cardiovascular diseases and diabetes.
We develop, conduct, evaluate and publish clinical and epidemiological studies either alone or in partnership with other health care institutions. In addition, we produce dossiers for early benefit assessments according to § 35a SGB V and benefit- or cost-benefit-assessments, as well as expert reports on drugs for regulatory agencies and other health institutions. We are committed to the principles of evidence-based medicine and scientific freedom.
The Institute of Pharmacology and Preventive Medicine is a partnership that has been registered with Munich District Court under the number PR 917.
Our clinical research activities are bundled in the IPPMed – Institute of Pharmacology and Preventive Medicine GmbH. It is a limited liability company which is registered with the Oldenburg District Court under the number HRB 209024.